Efficacy and Tolerability of BAF312 in Patients With Polymyositis
Condition: PolymyositisInterventions: Drug: Placebo; Drug: BAF312Sponsor: Novartis PharmaceuticalsRecruiting - verified November 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Polymyositis | Research